China's Top Departments: Pulmonary and Critical Care Medicine (PCCM) at Zhongshan Hospital, Fudan University
Founded in the 1930s, the PCCM department at Zhongshan Hospital is China's earliest pulmonary disease research laboratory. Now a National Clinical Key Specialty with world-leading IoT medicine, lung nodule guidelines, and advanced critical care including ECMO.
China's Top Departments: Pulmonary and Critical Care Medicine (PCCM) at Zhongshan Hospital, Fudan University
If you or a loved one is facing a complex respiratory condition — from lung cancer and COPD to rare interstitial lung diseases or critical respiratory failure — the Department of Pulmonary and Critical Care Medicine (PCCM) at Zhongshan Hospital, Fudan University, is one of China's most distinguished pulmonary centers.
Founded in the 1930s by Professor Wu Shaoqing, this department operates China's earliest pulmonary disease research laboratory. Nearly a century later, it has grown into a National Clinical Key Specialty, a Shanghai "Top Priority" Clinical Key Discipline, and a nationally recognized PCCM model unit.
The department is led by Professor Song Yuanlin, who also serves as Chair of the Infection Assembly of the Asia Pacific Society of Respirology. With 14 senior faculty, 9 doctoral supervisors, and nearly a century of clinical innovation, this is where China's most challenging pulmonary cases are resolved.
At ChinaMed Select, we've helped international patients access this world-class department for lung cancer treatment, COPD management, and complex respiratory conditions. Here's what you need to know.
A Legacy of Pulmonary Pioneers
The department's development represents nearly a century of collective contributions from generations of pulmonary physicians:
- Prof. Wu Shaoqing — Founder, pioneered tuberculosis control and pulmonary function testing in China
- Prof. Li Huade — Founded modern respiratory medicine; developed pulmonary function equipment, ventilators, and blood gas analyzers
- Prof. Jia Youming & Prof. Zhang Dunhua — Pioneered bronchoscopic intervention and medical thoracoscopy in China
- Prof. Niu Shanfu — Led non-invasive ventilation application and mask development
- Prof. He Lixian — Early exploration of pulmonary infections in immunocompromised hosts
- Prof. Bai Chunxue — First to propose "Internet of Things (IoT) Medicine"; led development of Asia-Pacific lung nodule guidelines
World-Class Platforms and Recognition
| Year | Achievement |
|---|---|
| 1930s | China's earliest pulmonary disease research laboratory established |
| 2004 | Shanghai Municipal Key Medical Discipline |
| 2007 | Shanghai Key Discipline |
| 2012 | Shanghai "Top Priority" Clinical Key Discipline; First batch of National Clinical Key Specialty |
| 2018 | PCCM Model Unit, Chinese Medical Doctor Association (Top 10 Nationwide) |
| 2019 | National PCCM Training Base and 6 Subspecialty Training Bases |
| 2021 | Shanghai Key Laboratory of Pulmonary Inflammation and Injury |
The department hosts the Shanghai Respiratory Disease Research Institute and manages the Shanghai Respiratory Medicine Clinical Quality Control Center.
Five Subspecialties — Comprehensive Pulmonary Care
1. Respiratory Critical Care
Originating in the late 1950s, this was among the first programs in China to adopt non-invasive positive pressure ventilation and lung-protective ventilation. Today, the department offers:
- ECMO (Extracorporeal Membrane Oxygenation) for severe respiratory failure
- Blood purification for multi-organ support
- Electrical Impedance Tomography (EIT) for real-time lung monitoring
- IoT-enabled eRICU — a smart respiratory intensive care unit
The department is nationally leading in respiratory failure management and critical care.
2. Chronic Airway Diseases (COPD & Asthma)
The department pioneered "Cloud + Terminal IoT Medicine" based on mobile phones, developing:
- World's first IoT PM2.5-enabled spirometer
- IoT-assisted management systems for COPD and asthma
- First global consensus on acute exacerbation of COPD (AECOPD)
- Over 20 IoT medicine demonstration bases nationwide
This technology-driven approach means patients receive continuous, personalized care even after leaving the hospital.
3. Lung Tumors & Interventional Pulmonology
This subspecialty has established several firsts in China:
- China's first comprehensive lung cancer diagnosis and treatment center (2002)
- First targeted therapy clinic for lung cancer (2007)
- Asia-Pacific Lung Nodule Evaluation Guidelines — the first international guideline led by a Chinese respiratory society
- China's first consensus on lung nodule diagnosis and treatment
- BaiDX IoT lung nodule diagnostic system
- Among the first in China to adopt medical thoracoscopy
- Designated by the National Health Commission as a pilot unit for electromagnetic navigation bronchoscopy in early lung cancer diagnosis
4. Pulmonary Infections
The department operates a large-scale microbiology laboratory combining traditional culture with molecular diagnostics. Particular expertise includes:
- Pulmonary infections in immunocompromised hosts
- Drug-resistant infections
- Hospital-acquired infection control
5. Interstitial Lung Disease (ILD)
The department employs advanced diagnostic techniques:
- Cardiopulmonary exercise testing
- Transbronchial cryobiopsy
- Multidisciplinary discussion (MDD) for ILD diagnosis
- Participation in multiple international multicenter clinical trials of antifibrotic drugs
- Cutting-edge research in AI-based quantitative imaging analysis
International Patient Services
Language Support
- English-speaking staff in the international patient department
- Professional medical interpreters available
- Treatment plans and reports provided in English
Insurance and Payment
Zhongshan Hospital accepts direct billing from major international insurers including MSH, BUPA, Allianz, and 40+ others.
Location and Contact
- Main Campus: 180 Fenglin Road, Xuhui District, Shanghai, China
- Geriatric Medical Center: 2560 Chunshen Road, Minhang District, Shanghai, China
- Tel: 021-64041990
- Appointment Hotline: 400-626-0121
- International Medical Email: [email protected]
What International Patients Should Know
When to Consider This Department
- Lung cancer requiring advanced diagnosis and multidisciplinary treatment
- Complex COPD or asthma not responding to standard therapy
- Rare interstitial lung diseases requiring specialized diagnosis
- Pulmonary infections in immunocompromised patients
- Respiratory failure requiring advanced critical care (ECMO, etc.)
- Second opinion on lung nodule evaluation or pulmonary treatment
The Treatment Journey
- Initial Consultation: Submit medical records, imaging (CT scans, pulmonary function tests) for remote review
- Treatment Plan: Receive detailed proposal including approach, timeline, and costs
- Pre-treatment Preparation: Additional tests, biopsies, or specialized imaging as needed
- Treatment: Duration varies by condition (outpatient to weeks of inpatient care)
- Recovery: Follow-up schedule established; remote monitoring via IoT systems for chronic conditions
- Return Home: Remote follow-up via video consultation; IoT-enabled home monitoring for COPD/asthma
Cost Estimates
| Service | Estimated Cost (USD) |
|---|---|
| Initial consultation | $100-300 |
| Comprehensive pulmonary function testing | $300-800 |
| CT-guided lung biopsy | $1,500-3,500 |
| Bronchoscopy with biopsy | $1,000-2,500 |
| Medical thoracoscopy | $5,000-12,000 |
| Lung cancer surgery (VATS) | $15,000-30,000 |
| ECMO support (per day) | $3,000-6,000 |
| ICU stay (per day) | $500-1,500 |
Note: These are estimates for international patients. Actual costs depend on case complexity and length of stay.
How ChinaMed Select Can Help
Complex pulmonary conditions require careful coordination. ChinaMed Select provides:
- Case Review: Submit your medical records for pre-evaluation
- Hospital Coordination: Direct communication with the international patient department
- Interpreter Services: Professional medical interpreters for all consultations
- Accommodation: Arrangement of housing near the hospital
- Post-treatment Care: Coordination of follow-up and remote monitoring setup
- Insurance Navigation: Assistance with direct billing claims
Contact ChinaMed Select for a free consultation about pulmonary treatment at Zhongshan Hospital.
Frequently Asked Questions
Q: How does Zhongshan Hospital's PCCM department compare to top pulmonary centers in the US or Europe?
A: The department's academic credentials are world-class — nearly a century of pulmonary research, leadership in Asia-Pacific guidelines, and pioneering IoT medicine. The key advantages are: significantly lower costs (60-80% less than US/Europe), access to innovative IoT-enabled chronic disease management, and comprehensive subspecialty care under one roof.
Q: I have a lung nodule that doctors in my country are monitoring. Can this department help?
A: Yes. Zhongshan Hospital led the development of the Asia-Pacific Lung Nodule Evaluation Guidelines. The BaiDX IoT lung nodule diagnostic system provides advanced analysis. Submit your CT scans for a second opinion — many patients receive clearer answers and treatment plans.
Q: How does the IoT medicine program work for COPD or asthma?
A: Patients receive IoT-enabled devices (spirometers, peak flow meters) that connect to the hospital's cloud platform. The medical team monitors your lung function remotely and adjusts treatment in real-time. This is particularly valuable for international patients who return home after treatment.
Q: What if I need ECMO or advanced critical care?
A: The department is nationally leading in respiratory failure management with full ECMO capabilities, blood purification, and IoT-enabled eRICU. International patients receive the same level of critical care as domestic patients.
Q: How long do I need to stay in Shanghai?
A: For outpatient consultations and diagnostics: 1-2 weeks. For lung cancer surgery: 2-3 weeks in hospital, 1-2 months in Shanghai for follow-up. For chronic disease management programs: initial 1-2 weeks, then remote monitoring from home.
Facing a complex pulmonary condition? Contact ChinaMed Select for a free consultation. We'll review your case, connect you with Zhongshan Hospital's PCCM team, and coordinate your entire treatment journey — from medical record translation to post-treatment remote monitoring.
Need personalized hospital recommendations?
Turn this research into an action plan: get tailored hospital recommendations matched to your condition, budget, and timeline.
✓ Free consultation · Response within 24 hours · 100+ international patients served